ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,840 | +4.4% | 2,305 | -0.5% | 0.14% | -4.9% |
| Q2 2023 | $206,792 | -17.0% | 2,317 | -0.3% | 0.14% | -44.4% |
| Q1 2023 | $249,287 | +89571.6% | 2,325 | +2.2% | 0.26% | +30.8% |
| Q4 2022 | $278 | -99.9% | 2,276 | -0.1% | 0.20% | 0.0% |
| Q3 2022 | $235,000 | +10.8% | 2,278 | +0.0% | 0.20% | +23.0% |
| Q2 2022 | $212,000 | -20.9% | 2,277 | -0.3% | 0.16% | +4.5% |
| Q1 2022 | $268,000 | -8.8% | 2,284 | +4.6% | 0.15% | +12.4% |
| Q4 2021 | $294,000 | -15.5% | 2,183 | -0.0% | 0.14% | +8.7% |
| Q3 2021 | $348,000 | +7.1% | 2,184 | -11.6% | 0.13% | +16.7% |
| Q2 2021 | $325,000 | +8.3% | 2,471 | +6.0% | 0.11% | -41.9% |
| Q1 2021 | $300,000 | -48.9% | 2,331 | -33.8% | 0.19% | -91.6% |
| Q4 2020 | $587,000 | +6.1% | 3,519 | -1.8% | 2.21% | +630.8% |
| Q3 2020 | $553,000 | +1.7% | 3,584 | -2.5% | 0.30% | -6.2% |
| Q2 2020 | $544,000 | +31.4% | 3,675 | 0.0% | 0.32% | +79.9% |
| Q1 2020 | $414,000 | -12.7% | 3,675 | +7.9% | 0.18% | +6.5% |
| Q4 2019 | $474,000 | +46.3% | 3,405 | +1.3% | 0.17% | -6.1% |
| Q3 2019 | $324,000 | -5.5% | 3,360 | +12.7% | 0.18% | +32.6% |
| Q2 2019 | $343,000 | – | 2,981 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |